3. Obstructive Shock (Mechanical Shock: Air/Fat/Amniotic Fluid Embolism)

Quick Recap

Cardiovascular System, Protocol 4/12. Also called "mechanical shock." This is the unifying framework for RV-afterload-driven shock states; massive PE and cardiac tamponade have their own dedicated protocols with full management detail — this protocol covers the shared pathophysiology plus air embolism, fat embolism, and amniotic fluid embolism syndrome in depth, and tension pneumothorax is covered fully in its own Respiratory-system protocol.

1. Definition

Obstructive (mechanical) shock = shock caused by acute mechanical obstruction to blood flow, most commonly an acute loss of pulmonary vascular cross-sectional area (direct obstruction or vasoconstriction) -> acute rise in pulmonary vascular resistance (PVR) -> RV strain/failure -> shock. Also includes non-pulmonary mechanical causes: cardiac tamponade (its own protocol) and tension pneumothorax (covered in the Pneumothorax protocol).

Four major etiologies covered here in depth: (1) massive pulmonary embolism (see dedicated PE protocol for full management), (2) air embolism, (3) fat embolism, (4) amniotic fluid embolism.

Key principle: multiple shock types can coexist — do not stop looking once one obstructive cause is found; e.g., arterial air embolism reaching the coronary circulation adds a cardiogenic component to the picture.

2. Pathophysiology

The pulmonary circulation is normally high-capacitance, low-resistance. The RV cannot acutely compensate for a mean pulmonary arterial pressure (mPAP) >40 mmHg — finding mPAP >40 without RV failure signs actually suggests a chronic/subacute process, not an acute one. In the absence of pre-existing cardiopulmonary disease, the rise in RV afterload/mPAP is directly proportional to the degree of pulmonary vascular obstruction/vasoconstriction; echocardiographic RV dysfunction can appear after just a 25-30% reduction in pulmonary vascular cross-sectional area. Patients with pre-existing cardiopulmonary disease can decompensate with much less obstruction. Once PVR rise exceeds RV compensatory capacity, a self-reinforcing deterioration occurs: RV dilation -> septal shift into LV -> reduced LV filling -> reduced cardiac output -> reduced coronary perfusion -> RV ischemia -> further RV dysfunction -> circulatory collapse.

Common findings across all obstructive/mechanical shock etiologies: tachycardia, hypotension, signs of end-organ hypoperfusion (oliguria, cool/mottled extremities, altered mentation); exam signs of decompensated RV failure (JVD, TR murmur, accentuated P2, hepatojugular reflux, Kussmaul sign); hypoxemia/tachypnea from V/Q mismatch; ECG sinus tachycardia +/- RV strain pattern; echo RV dilation/hypokinesis, TAPSE <17mm, TR, septal flattening; labs may show hyponatremia, elevated BNP, elevated troponin, elevated lactate. In catastrophic presentations, VF, PEA, or asystole may be the initial presentation.

3. Immediate Stabilization (ABCDE)

Airway/Breathing: treat hypoxemia; be cautious with positive pressure ventilation/high PEEP, which can further increase RV afterload and worsen an already RV-strained circulation.

Circulation:

• Rapid bedside echo (2D echo, or transesophageal Doppler/PA catheter if multiple shock etiologies are suspected simultaneously) to identify RV dysfunction and guide the specific etiology-directed therapy below
• Cautious fluid administration — unlike hypovolemic shock, aggressive fluids can worsen RV distension and further compromise LV filling via septal shift; small, closely monitored boluses only
• Norepinephrine typically preferred to support MAP/coronary perfusion pressure without excessive additional pulmonary vasoconstriction at usual doses
• Identify and treat the SPECIFIC obstructive cause immediately — generic shock resuscitation alone will not reverse the underlying mechanical problem

Checklist:

4-5. History and Examination

See dedicated protocols (PE, Cardiac Tamponade, Pneumothorax) for etiology-specific history/exam. General exam findings for any obstructive shock: JVD, TR murmur, accentuated P2, hepatojugular reflux, Kussmaul sign, cool/mottled extremities, altered mentation.

6. Air Embolism Syndrome (AES)

Mechanism: gas enters venous (or arterial) circulation via a pressure gradient favoring entrainment (open vein above right atrium, negative intrathoracic pressure) or direct injection/insufflation. Even a small -5 cmH2O gradient can entrain up to 100 mL/s of air through a 14G peripheral IV. Venous AES causes shock mainly via RVOT obstruction. Estimated lethal venous air dose ~200-300 mL (up to 500 mL if entrained slowly); as little as 50 mL entrained rapidly can cause hemodynamic compromise. Unlike thrombus/fat, gas is continuously cleared by alveolar-capillary diffusion — if the portal of entry is closed and RV can compensate, AES-induced shock should resolve as gas clears.

Arterial AES (via PFO/shunt, pulmonary vasodilator overwhelm, or venous overwhelm of pulmonary filtration capacity) typically does NOT cause mechanical shock, but coronary arterial gas entry causes myocardial ischemia/cardiogenic shock; cerebral arterial gas entry causes agitation, delirium, seizures.

Risk factors: open surgical site above the right atrium (craniotomy, C-section), laparoscopic/endoscopic gas insufflation, volume depletion, barotrauma, pulmonary vasodilator use, airway/lung biopsy, venous access device placement/removal, contrast injection, trauma.

Presentation: sense of impending doom, chest pain, respiratory distress, wheeze, cyanosis, hypoxemia, gasp reflex, mill-wheel murmur on auscultation (classic but insensitive), agitation/delirium/seizure if arterial.

Management:

• Eliminate the portal of gas entry immediately (occlude open vein/line, stop insufflation, flood surgical field with saline)
• Left lateral decubitus positioning (Durant's maneuver) — elevates RV above its outflow tract, promoting air migration away from the RVOT
• Air aspiration via central venous catheter (tip ~2cm below SVC/RA junction, aspirate through the distal port) can remove up to 50% of embolized gas with rapid hemodynamic improvement
• Refractory cardiac arrest: emergency thoracotomy with direct RV aspiration as a last resort
• Prevention: adequate hydration, proper positioning, avoid barotrauma, careful vascular access technique; capnography/precordial Doppler monitoring in high-risk procedures for early detection

7. Fat Embolism Syndrome (FES)

Mechanism: fat from necrotic bone marrow/adipocytes enters venous circulation after trauma/tissue injury -> mechanical pulmonary vascular obstruction + systemic inflammatory response. ~90% follow blunt trauma with pelvic/long bone fractures; risk rises with injury severity and number of marrow-containing bones involved. Circulating fat alone is common after orthopedic surgery and is NOT sufficient to cause FES — severity depends on fat volume/rate of embolization, immunogenicity, host inflammatory response intensity, and pre-existing cardiopulmonary disease.

Two-phase course: early shock is mechanical (RV failure from pulmonary vascular obstruction); 24-72 hours later, toxic free fatty acid metabolites drive systemic inflammation, acute lung injury, and end-organ dysfunction resembling septic shock physiology.

Classic triad (not always all present): hypoxemia, neurologic dysfunction, petechial rash involving axilla/upper trunk.

No specific diagnostic test — clinical diagnosis based on risk factors + presentation.

Management: supportive — restore hemodynamic stability, maintain oxygenation to prevent end-organ dysfunction. Some evidence supports prophylactic corticosteroids in high-risk patients before FES develops (e.g., major long-bone/pelvic fracture); no evidence supports corticosteroids once FES has already occurred.

8. Amniotic Fluid Embolism Syndrome (AFES)

Mechanism: amniotic fluid (containing water, electrolytes, hormones, fetal cellular material) enters maternal circulation via cervical/uterine wall/placental membrane disruption during labor/delivery or postpartum. Pathogenesis incompletely understood — combination of mechanical obstruction and an anaphylactoid/inflammatory response.

Risk factors: pregnancy, peripartum, postpartum (up to 48h), difficult labor, labor induction agents, amniocentesis, first/second trimester abortion, trauma.

Presentation: classic findings are acute-onset shock, hypoxemia, encephalopathy, coagulopathy/DIC — can be fulminant with circulatory collapse and death within hours; also agitation/delirium, seizures, fever/chills, nausea/vomiting, profuse hemorrhage with no obvious structural cause, fetal bradycardia/late decelerations. Survivors are frequently left with severe neurologic impairment.

Management: supportive, with early recognition being paramount — bedside 2D echo for rapid LV/RV assessment; transesophageal Doppler or PA catheter if multiple shock etiologies are in play (common in AFES, which frequently combines obstructive, cardiogenic, and hemorrhagic/DIC-driven distributive physiology simultaneously); aggressive coagulopathy/DIC management (see DIC protocol); requires close coordination between intensivist, obstetrician, and anesthesiologist. See also the dedicated Obstetric ICU protocols for full detail.

9. Massive Pulmonary Embolism

See the dedicated Pulmonary Embolism protocol (Respiratory System) for full definition, the new AHA/ACC 2026 Clinical Category system, risk stratification, and management including thrombolysis/catheter-directed therapy/surgical embolectomy/ECMO criteria. Key risk factors: immobilization, recent surgery (<3 months), prior VTE, malignancy, chronic cardiopulmonary disease, trauma, obesity, central venous catheters, hypercoagulable state.

10. Cardiac Tamponade and Tension Pneumothorax

See dedicated protocols: Cardiac Tamponade (Cardiovascular System) and Pneumothorax (Respiratory System, includes full tension pneumothorax management).

11. Investigations (General, Across Obstructive Shock Etiologies)

• Bedside: rapid 2D echo (RV size/function, septal position, effusion, IVC), ECG (sinus tachycardia, RV strain pattern), lactate
• Labs: troponin, BNP, hyponatremia screen, DIC panel if AFES suspected, lipase/pancreatic markers if relevant
• Etiology-specific: CTPA (PE), CT chest (fat embolism supportive findings), clinical/obstetric context (AFES — largely a clinical diagnosis of exclusion)

12. Consultation Matrix

13. Monitoring Framework

Continuous hemodynamic monitoring, serial echo/RV function trend, lactate trend, coagulation panel trend (especially AFES), watch for coexisting/evolving additional shock etiology.

14. Complications

RV failure/cardiac arrest, hypoxic brain injury (especially AFES, arterial air embolism), DIC (AFES), ARDS (FES, massive transfusion if hemorrhagic component present), recurrent embolization. Prevention: portal-of-entry elimination (air), prophylactic steroids in high-risk fracture patients (fat), careful line/procedure technique (air), obstetric vigilance (AFES). Rescue: emergency thoracotomy (air), ECMO consideration in refractory cases across etiologies.

15. Escalation & De-escalation

Escalate: worsening RV function/hemodynamics despite etiology-specific first-line therapy -> consider ECMO (VA) as bridge across multiple obstructive shock etiologies when RV failure is refractory.

De-escalate: underlying obstruction resolved/cleared, RV function recovering -> wean vasopressor support, transition to standard monitoring.

16. Documentation & Medicolegal Checklist

17. Key Guidelines / Reference Reviews

Grotberg JC. Mechanical Causes of Shock. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 6) — primary unifying reference for this protocol's framework.

18. Controversies

No unified severity scoring system exists across all obstructive shock etiologies (unlike PE's dedicated AHA/ACC categories) — air, fat, and amniotic fluid embolism management remain largely supportive/consensus-based given the rarity and difficulty of conducting RCTs in these conditions. Prophylactic corticosteroid use in high-risk fracture patients to prevent FES has some supporting evidence but is not universally adopted. AFES pathogenesis (mechanical vs anaphylactoid vs a hybrid mechanism) remains incompletely understood, limiting mechanism-targeted therapy development.

19. References

1. Grotberg JC. Mechanical Causes of Shock. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 6).
2. Mirski MA, Lele AV, Fitzsimmons L, et al. Diagnosis and treatment of vascular air embolism. Anesthesiology. 2007;106(1):164-177.
3. Mellor A, Soni N. Fat embolism. Anaesthesia. 2001;56(2):145-154.
4. Moore J, Baldisseri MR. Amniotic fluid embolism. Crit Care Med. 2005;33(10 suppl):S279-S285.
5. Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest. 2005;128(3):1836-1852.
6. Jorens PG, Van Marck E, Snoeckx A, et al. Nonthrombotic pulmonary embolism. Eur Respir J. 2009;34(2):452-474.

See also: Pulmonary Embolism (Respiratory System), Pneumothorax (Respiratory System), Cardiac Tamponade (Cardiovascular System) for full etiology-specific management.